Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial.
Maggio A, D'Amico G, Morabito A, Capra M, Ciaccio C, Cianciulli P, Di Gregorio F, Garozzo G, Malizia R, Magnano C, Mangiagli A, Quarta G, Rizzo M, D'Ascola DG, Rizzo A, Midiri M. Maggio A, et al. Among authors: malizia r. Blood Cells Mol Dis. 2002 Mar-Apr;28(2):196-208. doi: 10.1006/bcmd.2002.0510. Blood Cells Mol Dis. 2002. PMID: 12064916 Clinical Trial.
Potential myocardial iron content evaluation by magnetic resonance imaging in thalassemia major patients treated with Deferoxamine or Deferiprone during a randomized multicenter prospective clinical study.
Galia M, Midiri M, Bartolotta V, Morabito A, Rizzo M, Mangiagli A, Malizia R, Borsellino Z, Capra M, D'Ascola DG, Magnano C, Gerardi C, Rigano P, Maggio A; Multicenter Trial Group of the Society for the Study of Thalassemia and Haemoglobinopathies. Galia M, et al. Among authors: malizia r. Hemoglobin. 2003 May;27(2):63-76. doi: 10.1081/hem-120021538. Hemoglobin. 2003. PMID: 12779268 Clinical Trial.
Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Magnano C, Rizzo M, Caruso V, Gerardi C, Argento C, Campisi S, Cantella F, Commendatore F, D'Ascola DG, Fidone C, Ciancio A, Galati MC, Giuffrida G, Cingari R, Giugno G, Lombardo T, Prossomariti L, Malizia R, Meo A, Roccamo G, Romeo MA, Violi P, Cianciulli P, Rigano P. Maggio A, et al. Among authors: malizia r. Blood Cells Mol Dis. 2009 May-Jun;42(3):247-51. doi: 10.1016/j.bcmd.2009.01.002. Epub 2009 Feb 23. Blood Cells Mol Dis. 2009. PMID: 19233692 Clinical Trial.
HCV clearance among hemophiliacs and beta-thalassemics.
Di Marco V, Bronte F; Sicily Group for the Study of Thalassemia; Capra M, Gerardi C, Maggio A, Malizia R, Rizzo M. Di Marco V, et al. Among authors: malizia r. Gastroenterology. 2007 Apr;132(4):1634. doi: 10.1053/j.gastro.2007.03.007. Gastroenterology. 2007. PMID: 17418167 No abstract available.
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.
Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C. Maggio A, et al. Among authors: malizia r. Br J Haematol. 2009 Apr;145(2):245-54. doi: 10.1111/j.1365-2141.2009.07609.x. Epub 2009 Feb 19. Br J Haematol. 2009. PMID: 19236376 Free article. Clinical Trial.
Quantitative evaluation of oxidative stress status on peripheral blood in beta-thalassaemic patients by means of electron paramagnetic resonance spectroscopy.
Filosa A, Valgimigli L, Pedulli GF, Sapone A, Maggio A, Renda D, Scazzone C, Malizia R, Pitrolo L, Lo Pinto C, Borsellino Z, Cuccia L, Capra M, Canistro D, Broccoli M, Soleti A, Paolini M. Filosa A, et al. Among authors: malizia r. Br J Haematol. 2005 Oct;131(1):135-40. doi: 10.1111/j.1365-2141.2005.05734.x. Br J Haematol. 2005. PMID: 16173974 Free article.
Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.
Pantalone GR, Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C. Pantalone GR, et al. Among authors: malizia r. Hemoglobin. 2011;35(3):206-16. doi: 10.3109/03630269.2011.570674. Hemoglobin. 2011. PMID: 21599433 Clinical Trial.
Short stature and body proportion in thalassaemia.
Caruso-Nicoletti M, De Sanctis V, Capra M, Cardinale G, Cuccia L, Di Gregorio F, Filosa A, Galati MC, Lauriola A, Malizia R, Mangiagli A, Massolo F, Mastrangelo C, Meo A, Messina MF, Ponzi G, Raiola G, Ruggiero L, Tamborino G, Saviano A. Caruso-Nicoletti M, et al. Among authors: malizia r. J Pediatr Endocrinol Metab. 1998;11 Suppl 3:811-6. J Pediatr Endocrinol Metab. 1998. PMID: 10091151
41 results